-
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent
Elise A. Olsen, Sean J Whittaker, Rein Willemze, Lauren C. Pinter‐Brown, Francine M. Foss, Larisa J. Geskin, +28 more
184citations -
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails2020 Blood article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 3 patents
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Carolin Massalski, Sandra Kay Frank, Jürgen Sauter, +16 more
55citations -
Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs2023 Blood article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent
Saskia van der Velden, Thijs L. J. van Osch, Amina Seghier, Arthur E. H. Bentlage, Juk Yee Mok, Dionne M. Geerdes, +9 more
51citations -
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation2020 Blood article Biochemistry, Genetics and Molecular Biology Genetic Associations and Epidemiology Open access cited by 2 patents
Louisa Goumidi, Florian Thibord, Kerri L. Wiggins, Ruifang Li‐Gao, Mickael R. Brown, Astrid van Hylckama Vlieg, +22 more
48citations -
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent
Safa Najidh, Cornelis P. Tensen, Alita J. van der Sluijs‐Gelling, Cristina Teodósio, Davy Cats, Hailiang Mei, +8 more
47citations -
Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial
Marc Steffen Raab, Niels Weinhold, Klaus Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, +23 more
47citations -
A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity2020 Blood article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 4 patents
Marthe C.J. Roex, Lois Hageman, Sabrina A.J. Veld, Esther van Egmond, Conny Hoogstraten, Christian Stemberger, +4 more
16citations -
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness2021 Blood article Immunology and Microbiology Mast cells and histamine Open access cited by 1 patent
Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano, Paraskevi Kousteridou, Min Yuan, +11 more
6citations -
An Optimized Crovalimab Dose and Regimen Reduced the Formation of Drug-Target-Drug Complexes in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Phase I/II COMPOSER Trial
Jun‐ichi Nishimura, Antoine Soubret, Simon Buatois, Jean‐Eric Charoin, Sasha Sreckovic, Christoph Marcus Bucher, +21 more
3citations -
Polb 001, an Oral Broad-Spectrum Anti-Inflammatory with the Potential to Prevent Cytokine Release Syndrome (CRS)2023 Blood conference-abstract Immunology and Microbiology Immunotoxicology and immune responses cited by 3 patents
Emma J Searle, Liam Friel Tremble, Rakesh Popat, Digna T. de Bruin, Matthijs Moerland, Brendan Martin Buckley
3citations
16 results